Informação sobre produto
- 2,5,8,11-Tetraazatridecan-13-oic acid, 5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-
- 5,8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oic acid
- N,N-bis(2-{(carboxymethyl)[2-(methylamino)-2-oxoethyl]amino}ethyl)glycine
- DTPA-BMA
Dtpa-bma is an anticancer agent that acts as a kinase inhibitor. It has been shown to induce apoptosis in cancer cells by inhibiting the activity of kinases, which are enzymes that play a key role in cell signaling pathways. Dtpa-bma is an analog of Chinese hamster ovary (CHO) cell-derived ghrelin and is excreted in urine. This drug is effective against various types of cancer, including human tumors, and has been shown to inhibit tumor growth in vivo. Dtpa-bma is formulated as a cellulose-based resin for use in chromatography purification processes.
Propriedades químicas
Consulta técnica sobre: 3D-UEA89595 Dtpa-bma
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
